Home »
Academic Articles »
C »
Advances in microneedle-based drug delivery system for metabolic diseases: structural considerations, design strategies, and future perspectives
Advances in microneedle-based drug delivery system for metabolic diseases: structural considerations, design strategies, and future perspectives
Yao Li
(Zhejiang Provincial Key Laboratory for Water Environment and Marine Biological Resources Protection, College of Life and Environmental Science, Wenzhou University)
Qiu Chen
(Department of Endocrinology, The Third Affiliated Hospital of Wenzhou Medical University)
Tingting Wang
(Wenzhou Institute, University of Chinese Academy of Sciences)
Zengkai Ji
(Wenzhou Institute, University of Chinese Academy of Sciences)
Sagar Regmi
(Department of Radiation Oncology, University Hospital Seidman Cancer Center Cleveland)
Haibin Tong
(Zhejiang Provincial Key Laboratory for Water Environment and Marine Biological Resources Protection, College of Life and Environmental Science, Wenzhou University)
Jian Ju
(Wenzhou Institute, University of Chinese Academy of Sciences)
Aifang Wang
(The People’s Hospital of Yuhuan (Yuhuan People’s Hospital Health Community Group))
Journal: Journal of Nanobiotechnology
•
• BMC
• ISSN: 1477-3155
Abstract
Abstract As the prevalence of metabolic diseases such as diabetes and obesity continue to rise, the search for more effective and convenient treatments has become a crucial issue in medical research. Microneedles (MNs), as an innovative drug delivery system, have shown advantages in the treatment of metabolic diseases in recent years. MNs-based drug delivery system, which use MNs to deliver drugs directly to the subcutaneous tissue, improve drug bioavailability and reduce systemic side effects. This review aims to summarize the latest concepts, designs, and types of MNs, and to investigate the materials and manufacturing methods used in their construction. Subsequently, the mechanisms of drug delivery and graded release of MNs and recent research progress are further summarized. This article focuses on the application of MNs in the treatment of common metabolic diseases, with a special emphasis on the progress and optimization of diabetic and anti-obesity MNs. The main challenges and future perspectives in the production and evaluation of MNs, as well as in enhancing treatment efficacy and improving safety, are elucidated.
Yao Li, Qiu Chen, Tingting Wang, et al. (2025). "Advances in microneedle-based drug delivery system for metabolic diseases: structural considerations, design strategies, and future perspectives". Journal of Nanobiotechnology. https://doi.org/10.1186/s12951-025-03432-9